RAYMOND COHEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOLIFE SOLUTIONS INC

Filing Date Source Excerpt
2019-04-30 Raymond W. Cohen joined the Board in May 2006, and has served as Chairman of the Board since November 2013. ... The following table sets forth information regarding compensation earned by our non-employee directors for the year ended December 31, 2018. ... Raymond Cohen 50,000 Annual Cash Retainer, 100,000 Board and Committee Chair Fees, 90,000 Stock Awards, Total 240,000.
2020-05-29 Raymond Cohen joined the Board in May 2006 and has served as Chairman of the Board since November 2013. Mr. Cohen is an accredited public company director with extensive operating and corporate governance experience holding positions on the boards of publicly listed life science companies. Mr. Cohen currently serves as the Chief Executive Officer and member of the board of directors of Axonics Modulation Technologies, Inc., (NASDAQ: AXNX), a manufacturer of neuromodulation devices. The Board has determined that Mr. Cohen is qualified to serve as a director because of his extensive experience with public companies.

Data sourced from SEC filings. Last updated: 2026-02-03